![Hoe eenvoudige semantiek onze AI-citaties met 642% verhoogde [Nieuwe resultaten]](https://www.pharmamarketeer.nl/wp-content/uploads/2026/01/719-370x300.jpg)
Na het nieuws over het faillissement van het MC Slotervaart hoopten patiënten en medewerkers van het ziekenhuis in Amsterdam de afgelopen dagen voorzichtig op een overname. Dat laatste sprankje hoop is vandaag verdwenen...
AstraZeneca offloads RSV drug to Sobi for $1.5B, its largest divestiture in 5 years
AstraZeneca has just struck its third divestment deal since Oct. 30, handing off the U.S. rights to Synagis, a drug to prevent infections caused by respiratory syncytial virus (RSV), to Sweden’s Sobi.
NIH awards $3.5 million to continue development of robotic system for treating brain tumors
Researchers at Worcester Polytechnic Institute and Albany Medical College, along with corporate partners GE Global Research and Acoustic MedSystems Inc., have received a five-year, $3.5 million award from the National...
Wie volgt Vincent van den Boogert op als Marketeer of the Year?
Alle professionals in marketing worden opgeroepen kandidaten aan te dragen voor de Dutch Marketing Awards.
Pharmintech to be held in Bologna from April 10 to 12, 2019
Pharmintech, the event organized by BolognaFiere and dedicated to the pharmaceutical, nutritional, cosmeceutical and biotech industry, will be back in Bologna (Italy) in 2019, from April 10 to 12 focusing on what’s new...
Keytruda Gets FDA Approval for Hepatocellular Carcinoma
The approval was based on data from the KEYNOTE-224 study, a single-arm trial in patients with HCC who had disease progression on or after sorafenib or were intolerant to sorafenib; had measurable disease; and Child...
Grote Marketing Enquete: Marketeers omarmen purpose marketing
Purpose marketing, agile werken en het outsourcen van marketingactiviteiten staan hoog op de agenda van Nederlandse marketingprofessionals.
AZ’s Farxiga shows strength in largest ever SGLT2 inhibitor cardiovascular outcomes study
AstraZeneca has revealed new data for its sodium-glucose co-transporter 2 (SGLT2) inhibitor Farxiga (dapagliflozin) at the American Heart Association (AHA) Scientific Sessions 2018 in Chicago, showing that the drug...
Gilead NASH drug clears mid-stage trial, but rivals are looming
Gilead has new data backing up its liver disease candidate GS-9674 in non-alcoholic steatohepatitis (NASH), tipped as one of the next big growth markets for pharma.
Novartis’ heart failure drug Entresto proves superior to enalapril
Novartis has released new data for its heart failure treatment Entresto which could help convince doctors and payers of the drug’s value.
Miniaturized pipe organ could help improve quality of medical images
A miniaturized version of a musical instrument that could be used to improve the quality of medical images has been manufactured by researchers at the University of Strathclyde.
OR Slotervaart hoopvol over doorstart
De ondernemingsraad van het failliete MC Slotervaart staat positief tegenover de plannen voor een doorstart van het Amsterdamse ziekenhuis. De raad heeft het plan besproken en zegt hoopvol te zijn “omdat het een...
Handelsvergunning Bacicoline-B geschorst
Het College ter Beoordeling van Geneesmiddelen (CBG) heeft per 29 oktober de handelsvergunning voor Bacicoline-B (bacitracine/colistine/hydrocortison) geschorst.
AstraZeneca chief says Europe should pay more for drugs—and the U.S. should pay less
President Donald Trump has routinely bashed “global freeloading” on pharmaceuticals, and his administration last month unveiled a plan to try and lower some U.S. drug prices to international levels. Now, a top pharma...
‘Tekort aan pillen komt door lage prijzen’
Apothekers kampen nog steeds met een tekort aan anticonceptiepillen. De pil is meestal nog wel leverbaar, maar of dat ook zo blijft is nog maar de vraag. We maken de balans op met Lia Prins van Apotheek Vredeveld in...
Vijf tips voor meer bereik en sales met affiliate marketing
Door middel van een affiliate-programma kan een webshop via online partners zijn sales laten groeien. Maar hoe pak je dit zo effectief mogelijk aan? Vijf tips voor een optimale samenwerking met een affiliate:...
Mylan and Theravance’s COPD treatment gets FDA approval
Theravance Biopharma Inc and partner Mylan NV on Friday won U.S. regulatory approval for their treatment for a chronic lung condition that causes breathing-related problems.
Eisai’s Lenvima wins over NICE in liver cancer in just three months
Eisai has revealed that its multireceptor Tyrosine Kinase Inhibitor Lenvima (lenvatinib) has been recommended by NICE, meaning it can now be used routinely on the NHS in England and Wales for the first-line treatment of...
